Estrella Immunopharma, Inc. (ESLA)
0.39
-0.02
(-4.90%)
USD |
NASDAQ |
Nov 06, 10:12
Estrella Immunopharma Total Assets (Quarterly) : 1.825M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.825M |
| March 31, 2026 | 3.657M |
| December 31, 2025 | 3.177M |
| September 30, 2025 | 3.524M |
| June 30, 2025 | 2.980M |
| March 31, 2025 | 2.444M |
| December 31, 2024 | 3.141M |
| September 30, 2024 | 3.735M |
| June 30, 2024 | 4.454M |
| March 31, 2024 | 8.633M |
| December 31, 2023 | 9.447M |
| Date | Value |
|---|---|
| September 30, 2023 | 27.35M |
| June 30, 2023 | 10.26M |
| March 31, 2023 | 10.09M |
| December 31, 2022 | 9.986M |
| September 30, 2022 | 45.62M |
| June 30, 2022 | 45.38M |
| March 31, 2022 | 45.62M |
| December 31, 2021 | 45.80M |
| September 30, 2021 | 45.97M |
| June 30, 2021 | 3.441M |
| February 28, 2021 | 0.2542M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.256M |
| Shareholders Equity (Quarterly) | -7.431M |
| Current Ratio | 0.1971 |